Vaccines

Nucleic Acid-based Therapeutics Are Stepping into the Spotlight

April 15, 2023

The recent success of mRNA vaccines has opened the door for further and future development of nucleic acid-based therapies.

Learning to Think at Lightspeed

April 15, 2023

Actions combatting the next pandemic must be diverse, reliable, and sustainable.

Managing mRNA Instability

April 15, 2023

Unique solutions are required to protect inherently unstable messenger RNA.

The Role of Separation Techniques in the Analysis of mRNA Therapeutic Drug Substances and Drug Products

April 15, 2023

This article reviews a range of techniques available for separative analysis of mRNA therapeutics, their associated impurities, and delivery vehicles.

The Marriage of RNA and Mass Spectrometry

April 15, 2023

Considerable efforts have been made over the years to resolve the key issues of stability and delivery of RNA-based therapeutics.

Delivering on the Potential of mRNA Therapeutics

April 15, 2023

The complexity of the RNA production process creates challenges.

Unpacking Precision Vaccines with Nicole Lewis (World Vaccine Conference 2023)

April 06, 2023

Nicole Lewis, PVP Program Manager at Boston Children's Hospital, discusses the science behind precision vaccines, a form of personalized vaccines.

Vaccine Development Builds on COVID-19 Breakthroughs

March 02, 2023

Advances in vaccine development are creating partnerships and stimulating clinical trials to develop new mRNA applications.

Investigational Personalized mRNA Cancer Vaccine Gains Breakthrough Therapy Designation from FDA

February 28, 2023

Moderna and Merck’s investigational personalized mRNA cancer vaccine has been granted Breakthrough Therapy Designation by FDA.

The COVID-19 Pandemic and Its Positive Impact on RNA Drug Development

February 15, 2023

The COVID-19 pandemic helped to showcase RNA molecules and their therapeutic potential. There were also lessons learned in terms of drug delivery, manufacturing, logistics, and storage.